Reactivation of Apparently Inactive Cases of Pulmonary Tuberculosis

Reactivation of Apparently Inactive Cases of Pulmonary Tuberculosis.

Untreated inactive pulmonary tuberculosis. Risk of reactivation.

Reactivation of Pulmonary Tuberculosis following Treatment of Myelofibrosis with Ruxolitinib

Ruxolitinib is widely in use for treatment of myeloproliferative disorders. It causes inhibition of the Janus kinase (JAK) signal transducer and activation of transcription (STAT) pathway, which plays a key role in the underlying pathophysiology of myeloproliferative diseases. We describe a case of reactivation pulmonary tuberculosis in a retired physician while on treatment with ruxolitinib. W...

A STUDY OF MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE IN PULMONARY TUBERCULOSIS

Tuberculosis remains a major public health problem in both developing and developed countries. Drug-resistant tuberculosis is an increasing health problem and serious challenge to tuberculosis (TB) control programs. Information about the susceptibility pattern of Mycobacterium tuberculosis isolates against anti-tuberculosis drugs is an important aspect to TB control. The objectives of the s...

Persistent sle activity related to untreated reactivation of pulmonary tuberculosis

Methods WLS was diagnosed SLE at the age of 16 with fever, rash, oral ulcers, cytopenia, lupus nephritis (type II and III), retinal vasculitis and positive anti dsDNA. She was started on systemic steroid and Azathioprine. Symptoms became better and steroid was gradually tapered. However 3 months later she developed relapse of lupus activity with worsening lupus nephritis (active urinary sedimen...